அஃப் கல்லூரி ஆஃப் மருந்து துறை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

May 4, 2021 By Bill Levesque GAINESVILLE, Fla. (May 4, 2021)  University of Florida Health researchers recently became the first to temporarily implant a new device in a patient with congestive heart failure, a procedure that one day could help physicians manage this potentially deadly condition. Physicians in the UF College of Medicine’s department of urology and division of cardiovascular medicine performed the first-in-human use of the JuxtaFlow® renal negative pressure treatment device in April after enrolling the first patient in a clinical trial to evaluate its safety and effectiveness. UF Health hopes to enroll up to 10 patients in the trial. Each patient will receive the treatment for 24 hours while they are continually monitored by a member of the research team. After the device is removed, patients will continue to be closely followed for a month.

John erbeyEileenm handbergDavida cofrinAlexm parkerUniversity of florida healthUf college of medicineUf healthUf college of medicine departmentStrataca systems ltdFlorida healthStrataca systemsபல்கலைக்கழகம் ஆஃப் புளோரிடா ஆரோக்கியம்அஃப் கல்லூரி ஆஃப் மருந்துஅஃப் ஆரோக்கியம்அஃப் கல்லூரி ஆஃப் மருந்து துறைபுளோரிடா ஆரோக்கியம்